4.7 Review

Emerging Therapeutic Applications for Fumarates

期刊

TRENDS IN PHARMACOLOGICAL SCIENCES
卷 42, 期 4, 页码 239-254

出版社

CELL PRESS
DOI: 10.1016/j.tips.2021.01.004

关键词

-

资金

  1. Netherlands Heart Institute
  2. Australian Research Council [CE140100003, DP180101581]
  3. National Institutes of Health [RF1 NS113840]

向作者/读者索取更多资源

Fumarates have shown efficacy in treating psoriasis and multiple sclerosis due to their antioxidative, immunomodulatory, and neuroprotective properties. However, their exact mechanisms of action are not fully understood, requiring further research. Consideration of administration route, dosage, treatment timing, frequency, and duration is important in optimizing their clinical application.
Fumarates are successfully used for the treatment of psoriasis and multiple sclerosis. Their antioxidative, immunomodulatory, and neuroprotective properties make fumarates attractive therapeutic candidates for other pathologies. The exact working mechanisms of fumarates are, however, not fully understood. Further elucidation of the mechanisms is required if these drugs are to be successfully repurposed for other diseases. Towards this, administration route, dosage, and treatment timing, frequency, and duration are important parameters to consider and optimize with clinical paradigms in mind. Here, we summarize the rapidly expanding literature on the pharmacokinetics and pharmacodynamics of fumarates, including a discussion on two recently FDA-approved fumarates Vumerity (TM) and Bafiertam (TM). We review emerging applications of fumarates, focusing on neurological and cardiovascular diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据